COMP <GO>
MSA vs UNH // FORWARD P/E MULTIPLE
MSA Safety Incorporated (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MSA 5
— UNH 8
▲ FORWARD P/E MULTIPLE LEADER: UNH
LAST: $178.57 (-0.33%) • MKT CAP: $6.89B
forward-pe
23.1x
LAST: $406.97 (-0.96%) • MKT CAP: $365.29B
forward-pe
17.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MSA VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MSA | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.50% | 88.57% | -42.07 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.60% | 11.47% | +5.13 | MSA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 16.5x | +0.52 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.27% | 6.47% | -2.20 | UNH | /fcf-yield <GO> |
| Operating Margin | 19.80% | 4.82% | +14.98 | MSA | /operating-margins <GO> |
| Net Profit Margin | 14.90% | 3.14% | +11.76 | MSA | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 6.46% | -2.76 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.19% | 2.32% | -1.13 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 3.12 | +2.71 | MSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.11% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.2 | 57.4 | -13.20 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.33 | +0.54 | MSA | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 23.1x | 17.7x | +5.36 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.89B | $365.29B | -$358.41B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MSA REV | UNH REV | MSA GROSS % | UNH GROSS % | MSA FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $447.57B | 46.5% | 88.7% | $295.4M | $16.07B |
| FY 2024 | $1.81B | $400.28B | 47.6% | 88.3% | $242.2M | $20.70B |
| FY 2023 | $1.79B | $371.62B | — | 89.6% | $12.4M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MSA // BETA 0.87
UNH // BETA 0.33